We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MO icon
101
Altria Group
MO
$109B
$142K 0.03%
2,064
– –
PCG icon
102
PG&E
PCG
$37.5B
$141K 0.03%
2,200
– –
EQR icon
103
Equity Residential
EQR
$24.7B
$139K 0.03%
2,011
– –
MRK icon
104
Merck
MRK
$323B
$138K 0.03%
2,501
– –
VFC icon
105
VF Corp
VFC
$5.86B
$138K 0.03%
2,392
+480
+25% +$28.4K
UL icon
106
Unilever
UL
$135B
$122K 0.03%
2,267
+1,200
+112% +$61.6K
SYT
107
DELISTED
Syngenta Ag
SYT
$119K 0.03%
1,550
+1,000
+182% +$80.9K
ZTS icon
108
Zoetis
ZTS
$30.9B
$116K 0.03%
2,446
+1,300
+113% +$61.4K
GLD icon
109
SPDR Gold Trust
GLD
$143B
$114K 0.03%
900
+500
+125% +$60.2K
POT
110
DELISTED
Potash Corp Of Saskatchewan
POT
$111K 0.03%
6,850
+1,500
+28% +$25.1K
OLED icon
111
Universal Display
OLED
$4.16B
$108K 0.03%
+1,600
New +$98.3K
CWT icon
112
California Water Service
CWT
$3.06B
$105K 0.02%
3,000
– –
INFO
113
DELISTED
IHS Markit Ltd. Common Shares
INFO
$101K 0.02%
+3,100
New +$105K
LLY icon
114
Eli Lilly
LLY
$1.1T
$98K 0.02%
1,250
– –
STT icon
115
State Street
STT
$51.3B
$92K 0.02%
1,700
-450
-21% -$26.9K
TFCFA
116
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$92K 0.02%
+3,400
New +$99.1K
AU icon
117
AngloGold Ashanti
AU
$49.2B
$90K 0.02%
5,000
– –
D icon
118
Dominion Energy
D
$59.1B
$90K 0.02%
+1,158
New +$84K
META icon
119
Meta Platforms (Facebook)
META
$1.52T
$86K 0.02%
+750
New +$86.4K
CAT icon
120
Caterpillar
CAT
$385B
$84K 0.02%
1,100
-400
-27% -$30K
EL icon
121
Estee Lauder
EL
$31.5B
$82K 0.02%
+900
New +$84K
SWN
122
DELISTED
Southwestern Energy Company
SWN
$82K 0.02%
6,504
+1,609
+33% +$19.5K
BXP icon
123
Boston Properties
BXP
$10.8B
$80K 0.02%
606
– –
NSM
124
DELISTED
Nationstar Mortgage Holdings
NSM
$78K 0.02%
6,940
-325
-4% -$3.77K
ALL icon
125
Allstate
ALL
$68.2B
$77K 0.02%
+1,100
New +$73.7K
3 4
5
6 7

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.